Journal of General Internal Medicine

, Volume 35, Issue 1, pp 392–393 | Cite as

Missed Opportunity for HIV Prevention Among a High-Risk Population of Women Experiencing Intimate Partner Violence

  • Melissa E. DichterEmail author
  • Shannon N. Ogden
  • Kylee J. Clyatt
  • Christopher B. Roberts
Concise Research Report


HIV pre-exposure prophylaxis (PrEP), a daily pill combining two antiretroviral agents, tenofovir disoproxil fumarate/emtricitabine (TDF/FTC), has been shown to be effective in preventing HIV transmission in men and women and is recommended for those at increased risk of HIV.1 Experience of intimate partner violence (IPV) increases HIV risk for women,2 and women receiving care in the Veterans Health Administration (VHA) experience substantial rates of IPV.3 Given this risk and the availability of PrEP as a prevention tool in VHA, we sought to examine the association between recent IPV exposure disclosed to VHA providers through routine screening and HIV diagnosis, testing, and PrEP prescriptions among this population.


Data were extracted from patient medical records through the VHA corporate data warehouse for all female patients routinely screened for past-year IPV across 13 VHA facilities between April 2014 and 2016 (for more information on study methods, see...



The authors thank Maggie Czarnogorski for the thoughtful contributions to the study design.

Funding Information

This study was funded by the U.S. Department of Veterans Affairs, Health Services Research and Development (VA HSR&D; IIR 15-142; PI: Dichter).

Compliance with Ethical Standards

Conflict of Interest

The authors declare that they do not have a conflict of interest.


  1. 1.
    US Centers for Disease Control and Prevention, US Public Health Service. Preexposure prophylaxis for the prevention of HIV infection in the United States—2017 update: a clinical practice guideline. Available at: Accessed May 2, 2019.
  2. 2.
    Phillips DY, Walsh B, Bullion JW, Reid PV, Bacon K, Okoro N. The intersection of intimate partner violence and HIV in U.S. women: a review. J Assoc Nurses AIDS Care. 2014;25(1 Suppl):S36–S49.CrossRefGoogle Scholar
  3. 3.
    Dichter ME, Haywood TN, Butler AE, Bellamy SL, Iverson KM. Intimate partner violence screening in the Veterans Health Administration: demographic and military service characteristics. Am J Prev Med. 2017;52(6):761–768.CrossRefGoogle Scholar
  4. 4.
    Willie TC, Kershaw T, Campbell JC, Alexander KA. Intimate partner violence and PrEP acceptability among low-income, young black women: exploring the mediating role of reproductive coercion. AIDS Behav. 2017;21:2261–2269.CrossRefGoogle Scholar
  5. 5.
    Roberts ST, Haberer J, Celum C, et al. Intimate partner violence and adherence to HIV Pre-exposure Prophylaxis (PrEP) in African women in HIV serodiscordant relationships: a prospective cohort study. J Acquir Immune Defic Syndr. 2016;73:313–322.CrossRefGoogle Scholar

Copyright information

© Society of General Internal Medicine 2019

Authors and Affiliations

  • Melissa E. Dichter
    • 1
    • 2
    Email author
  • Shannon N. Ogden
    • 3
  • Kylee J. Clyatt
    • 4
  • Christopher B. Roberts
    • 1
  1. 1.Center for Health Equity Research and PromotionCrescenz VA Medical CenterPhiladelphiaUSA
  2. 2.School of Social Work, College of Public HealthTemple UniversityPhiladelphiaUSA
  3. 3.Department of Health, Law, Policy and ManagementBoston University School of Public HealthBostonUSA
  4. 4.Lankenau Medical CenterMain Line HealthWynnewoodUSA

Personalised recommendations